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Boron deprivation experiments with humans have yielded some persuasive findings for the hypothesis that boron is an essential nutrient. In the first
nutritional study with humans involving boron, 12 postmenopausal women first were fed a diet that provided 0.25 mg boron/2000 kcal for 119 days,
and then were fed the same diet with a boron supplement of 3 mg boron/day for 48 days. The boron supplementation reduced the total plasma
concentration of calcium and the urinary excretions of calcium and magnesium, and elevated the serum concentrations of 17f,-estradiol and testos-
terone. This study was followed by one in which five men over the age of 45, four postmenopausal women, and five postmenopausal women on
estrogen therapy were fed a boron-low diet (0.23 mg/2000 kcal) for 63 days, then fed the same diet supplemented with 3 mg boron/day for 49
days. The diet was low in magnesium (115 mg/2000 kcal) and marginally adequate in copper (1.6 mg/2000 kcal) throughout the study. This experi-
ment found higher erythrocyte superoxide dismutase, serum enzymatic ceruloplasmin, and plasma copper during boron repletion than boron deple-
tion. The design of the most recent experiment was the same as the second study, except this time the diet was adequate in magnesium and cop-
per. Estrogen therapy increased plasma copper and serum 17p-estradiol concentrations; the increases were depressed by boron deprivation.
Estrogen ingestion also increased serum immunoreactive ceruloplasmin and erythrocyte superoxide dismutase; these variables also were higher
during boron repletion than depletion for all subjects, not just those ingesting estrogen. Dietary boron had no effect on those variables in the men
and women not ingesting estrogen. These findings suggest that boron can both enhance and mimic some effects of estrogen ingestion. The find-
ings from all three studies are consistent with the hypothesis that boron has an essential function that affects macromineral and cellular metabolism
at the membrane level. - Environ Health Perspect 102(Suppl 7):59-63 (1994)
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Results Human Experiments
1 and 2
Boron deprivation experiments with ani-
mals and humans have yielded some
persuasive findings for the hypothesis that
boron is nutritionally essential. In experi-
mental animals, boron deprivation appar-
ently affects the function or composition of
several body systems, including the
skeleton, kidney, and brain (1,2). The vari-
ables affected by boron deprivation are
associated with the metabolism of several
other nutrients including calcium, copper,
and nitrogen (1,2). Responses to low
dietary boron have been most marked
when an experimental animal has had to
respond to a stressful situation that
adversely altered hormonal or cellular
membrane status such as the deprivation of
calcium, cholecalciferol, magnesium, or
potassium (1,2). Therefore, the first nutri-
tional study of boron (B) with humans
used postmenopausal women (3,4); they
undergo hormonal changes during peri-
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menopause associated with an increased
loss ofcalcium from bone or the body.
Twelve postmenopausal women first
were fed a diet that provided 0.25 mg
B/2000 kcal for 119 days and then were
fed the same diet with a boron supplement
of 3 mg/day for 48 days. During the
experiment, seven ofthe women were fed a
diet low in magnesium (116 mg/2000
kcal); the other five had their diet supple-
mented with 200 mg Mg/day. The boron
supplementation of the boron-deprived
women decreased the urinary excretion and
plasma concentration of calcium and mag-
nesium, decreased the urinary excretion
and plasma concentration ofphosphorus in
the women fed the magnesium-low diets,
and increased plasma testosterone and 17p-
estradiol concentrations. Generally, the
effects ofboron deprivation, or supplemen-
tation, seemed more marked in the women
fed the magnesium-low diet.
Another study was performed with five
men over the age of 45, nine post-
menopausal women (five postmenopausal
women on estrogen therapy) and one pre-
menopausal woman (originally thought to
be postmenopausal). They were fed a
boron-low diet, or 0.23 mg/2000 kcal for
63 days (5,6). Then they were fed the
same diet supplemented with 3 mg B/day
for 49 days. The diet was low in magne-
sium, 115 mg/2000 kcal, and marginally
adequate in copper, 1.6 mg/2000 kcal,
throughout the study. When all 15 sub-
jects were in the comparison, serum calci-
tonin, 25-hydroxycholecalciferol and ceru-
loplasmin concentrations, plasma copper
concentration and erythrocyte superoxide
dismutase activity were lower whereas
serum creatinine, glucose, and blood urea
nitrogen concentrations were all higher
during the boron depletion period than
the boron repletion period. Boron supple-
mentation of the boron-deprived women
on estrogen therapy, but not the other two
groups, also tended to increase serum 17,-
estradiol concentrations. Table 1 shows
the nature of the changes induced by
dietary boron in erythrocyte superoxide
dismutase, serum 17p3-estradiol, plasma
copper, and serum glucose.
Discussion-Human
Experiments 1 and 2
The two human experiments described
above yielded a bewildering and surprising
array of significant findings, considering
that boron has a biochemical role apparent-
ly so subtle it was considered nutritionally
unimportant until the 1980s. However, a
close analysis of the findings from these
two experiments indicates that boron
affects many of the same variables as calci-
um. Analysis suggests this similarity occurs
because both elements affect a similar sys-
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Table 1. Effect of boron on erythrocyte superoxide dismutase (SOD) activity, and plasma copper, serum glucose,
and serum 17,-estradiol concentrations in subjects fed a diet low in magnesium and copper. a
SOD, 170-estradiol, Copper, Glucose,
Dietaryboronb U/g Hb pg/ml pg/dl mg/dl
Men over age 45 (n= 5)
0 2287 33 91 94
3 2552 35 93 90
pvalue 0.41 0.50 0.52 0.21
Postmenopausal women (n= 4)
0 2213 23 127 94.
3 2386 18 128 88
pvalue 0.57 0.26 0.75 0.007
Postmenopausal women on
estrogen therapy(n=5)
0 2160 107 141 91
3 2736 145 152 86
pvalue 0.04 0.09 0.03 0.009
Above combined plus one
premenopausal woman (n= 15)
0 2257 52c 117 93
3 2578 64 c 122 88
pvalue 0.03 0.13 0.03 0.0004
aThere was a depletion period of 63 days when no boron supplement was given. This was followed by a repletion
period of49 days when the boron supplement was given. Values obtained during the last 42 days ofdepletion and
last 35 days of repletion were compared (5,6). bAmount of boron (B) as sodium borate supplemented per day to a
dietcontaining 0.25 mg B, 115 mg Mg and 1.6mg Cu/2000 kcal. cValues do not includethe premenopausal woman.
Table 2. Effect of boron on mean corpuscular hemoglobin content (MCH), hemoglobin concentration, hematocrits,
and platelet counts in subjects fed a diet apparentlyadequate in all nutrients.
MCH, Hemoglobin, Hematocrit, Platelets,
Dietaryboronb pg g/dl % 109/l
Men overage 45(n=4)
0 30.4 14.7 43.4 280
3 31.9 14.8 42.5 256
pvalue 0.003 0.45 0.03 0.008
Postmenopausal women (n=4)
0 29.6 12.9 38.2 312
3 30.6 13.1 37.8 278
pvalue 0.008 0.26 0.42 0.007
Postmenopausal women on
estrogen therapy(n=5)
0 30.3 13.0 38.7 297
3 31.8 13.3 37.5 268
pvalue 0.01 0.02 0.003 0.007
Above combined plus one
premenopausal woman (n= 14)
0 30.1 13.4 39.8 297
3 31.3 13.6 38.9 269
pvalue 0.0001 0.007 0.0001 0.0001
aThere was a depletion period of 63 days when no boron supplement was given followed by a repletion period of
49 days when the boron supplement was given. Values obtained during the last 35 days of depletion and the last
35 days of repletion were compared (8). bAmount of boron(B) as sodium borate supplemented perdayto a diet con-
taining 0.25mg B/2000 kcal.
tem, or systems (which indirecdy may influ- presence ofone or both ofthe elements, cel-
ence many other variables). Based on plant lular signal transduction would alter hor-
studies involving boron, the chemical prop- mone action, or transmembrane signaling.
erties ofboron, and the known biochemical These alterations would affect a large array
functions ofcalcium, a plausible hypothesis ofvariables including those associated with
is that boron and calcium are both involved hematopoiesis, erythropoiesis, macromin-
in maintaining cell membrane structure and eral and electrolyte metabolism, and even
function and also affect cellular signal trans- the response to estrogen therapy.
duction. When modified by a change in the Unfortunately, in the first two human
studies, examination of the specific effect
ofboron on these processes was prevented
because the studies were complicated by
diets low in magnesium and marginal in
copper, both dietary substances that also
affect these processes. To rectify this over-
sight, a third experiment recently was
completed with the subjects consuming a
diet apparently adequate in all nutrients
(including copper and magnesium).
Experimental Design and
Methods-Human
Experiment 3
In this third study, the subjects were four
men over the age of 45, nine post-
menopausal women (five postmenopausal
women on estrogen therapy) and-once
again-one women who was thought to be
postmenopausal but estrogen analyses dur-
ing the study revealed that she was not.
The subjects were fed a 3-day menu rota-
tion diet that contained conventional
foods including beef, pork, rice, bread, and
milk, but was low in fruits and vegetables.
The energy in the diet was 11% protein,
54% carbohydrate, and 35% fat. During
the first 32 days of the experiment, the
diet provided only 1.7 mg copper per
2000 kcal; this was lower than intended.
So, from day 33 onward, the diet was sup-
plemented so as to contain 2.4 mg ofcop-
per per 2000 kcal. Also, at an intake of
2000 kcal, the diet provided 680 mg of
calcium, 300 mg ofmagnesium, 450 IU of
cholecalciferol and only 0.25 mg ofboron.
After a 14-day equilibration period, there
was a 63-day depletion period during
which the basal low-boron diet was fed;
this was followed by a 49-day repletion
period when the diet was supplemented
with 3 mg of boron per day. To limit the
influence of dietary factors other than
boron depletion (including the increase in
dietary copper at day 32) and to assure
boron repletion had occurred, only the last
35 days ofeach dietary period were used in
the statistical analyses. For each variable, a
mean was computed for the dietary period
ofeach volunteer. Paired t-tests were then
used to test for dietary effects (7). In these
tests, each individual served as his or her
own control.
Results and Discussion-
Human Experiment 3
Dietary boron affected indices associated
with erythropoietic or hematopoietic activ-
ity (8). That is, boron supplementation
after boron depletion decreased hematocrit,
red blood cell count, and platelet count,
but increased total hemoglobin and mean
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Table 3. Effect of boron on erythrocyte superoxide dismutase (SOD) activity, and serum 17p-estradiol, plasma
copper, and serum immunoreactive ceruloplasmin concentrations in subjects fed a diet apparently adequate in all
nutrients. a
SOD, 170-estradiol, Copper, Ceruloplasmin,
Dietary boronb U/g Hb pg/ml pg/dl mg/day
Men over age 45(n=4)
0 3091 20 83 25
3 3231 17 86 28
pvalue 0.79 0.12 0.14 0.06
Postmenopausal women (n= 4)
0 2666 11 107 30
3 3169 11 108 33
pvalue 0.04 0.86 0.71 0.06
Postmenopausal women on
estrogen therapy(n= 5)
0 2520 99 146 42
3 3327 157 159 50
pvalue 0.03 0.02 0.04 0.05
Above combined plus one
premenopausal woman (n= 14)
0 2735 c 48 c 115c 33
3 3243 c 69 c 121c 38
pvalue 0.04 0.06 0.02 0.002
aThere was a depletion period of 63 days when no boron supplement was given followed by a repletion period of
49 days when the boron supplement was given. Values obtained during the last 35 days of depletion and the last
35 days of repletion were compared (9). bAmount of boron (B) as sodium borate supplemented perdayto a dietcon-
taining 0.25 mg B/2000 kcal. cValues do not includethe premenopausal woman.
Table 4. Effect of boron on serum 25-hydroxycholecalciferol (25-OH-D3) concentration, and urinary hydroxyproline
(HP) and calcium excretion in subjects fed a diet apparently adequate in all nutrients. a
25-OH-D3, HP, HP/creatinine, Calcium,
Dietary boron b ng/ml mmole/day ratio g/day
Men overage 45 (n=4)
0 18 0.0418 0.0038 0.263
3 26 0.0470 0.0044 0.256
pvalue 0.34 0.36 0.19 0.74
Postmenopausal women (n= 4)
0 18 0.0546 0.0082 0.182
3 20 0.0706 0.0101 0.204
pvalue 0.75 0.05 0.09 0.10
Postmenopausal women on
estrogen therapy(n= 5)
0 18 0.0520 0.0077 0.162
3 30 0.0609 0.0092 0.163
pvalue 0.06 0.05 0.16 0.94
Above combined plus one
premenopausal woman (n= 14)
0 18 0.0495 0.0069 0.198
3 25 0.0601 0.0082 0.205
pvalue 0.04 0.001 0.006 0.36
aThere was a depletion period of 63 days when no boron supplement was given followed by a repletion period of
49 days when the boron supplement was given. Values obtained during the last 35 days of depletion and the last
35 days of repletion were compared (8,9). bAmount of boron (B) as sodium borate supplemented per day to a diet
containing 0.25 mg B/2000 kcal.
corpuscular hemoglobin concentration and
content. Table 2 shows the nature ofsome
of these changes. Mean corpuscular hemo-
globin content (MCH) slightly decreased
between the start ofthe study and the end
of boron depletion, and then steadily
increased during boron repletion. Whether
the statistical analysis was by each group,
i.e., men, women, and women on estrogen
therapy, or as a group of 14, the difference
in MCH between the last 35 days of each
dietary period was significant. For instance,
when all 14 subjects were used in the com-
parison, the difference was 30.1 vs 31.3
and was significant at the 0.0001 level. In
contrast to the MCH and hemoglobin con-
centration, hematocrits stayed fairly con-
stant throughout boron depletion, but
decreased after boron supplementation
began. The difference between the last 35
days of each period was 39.8 vs 38.9, and
was significant at the 0.0001 level. Also,
during boron depletion, platelet counts
were elevated. Two subjects actually had
platelet counts of over 400 x 109 per liter.
After boron supplementation began, all
platelet counts dropped below 300 x 109
per liter.
The changes in blood variables that have
been presented are all within normal ranges
for adults and are not of clinical signifi-
cance. But the changes are statistically sig-
nificant and, because of their magnitude,
they are most likely indirectly the result of
boron altering some cellular function or
structure which can influence blood cell or
hemoglobin formation.
In the third and latest experiment, boron
supplementation after boron deprivation
increased erythrocyte superoxide dismutase
activity in postmenopausal women on
estrogen therapy, and (as shown in Table
3) in postmenopausal women not ingesting
estrogen. Table 3 also shows that estrogen
therapy increased serum 170-estradiol and
plasma copper concentrations in the post-
menopausal women. For both variables,
the elevation was significantly enhanced by
boron supplementation. These changes
were similar to those found with these two
variables in the second human boron
experiment when the diet was low in mag-
nesium and marginal in copper. In both
experiments, serum 17,B-estradiol and plas-
ma copper concentrations were not signifi-
cantly affected by the dietary boron
changes in men and those postmenopausal
women not on estrogen therapy.
The finding that physiologic amounts of
boron supplementation after boron depri-
vation causes higher peak serum 17p-estra-
diol concentrations in women ingesting
estrogen suggests that boron can enhance
estrogen absorption or decrease 170I-estra-
diol breakdown or excretion. This effect of
boron on serum 17,-estradiol was the most
likely reason for the significant increase in
plasma copper concentration. In other
words, because estrogen increases plasma
copper, and boron increases estrogen reten-
tion or concentration in blood, boron-
through estrogen-affected plasma copper
concentrations.
Because of the effects on copper and
170-estradiol, other variables that seemed
responsive to estrogen therapy were exam-
ined to see if dietary boron affected the
response in the same way. It was found that
boron affected some other variables respon-
sive to estrogen therapy. However, for most
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of these, the boron supplementation
seemed to mimic, rather than enhance, the
effects ofestrogen therapy. For example, as
shown in Table 3, serum immunoreactive
ceruloplasmin apparently was increased by
estrogen. Boron supplementation after
boron deprivation increased this variable in
all groups in a similar fashion. Unlike with
plasma copper, the change did not occur
only in the postmenopausal women ingest-
ing estrogen. A similar effect was obtained
with plasma triglycerides (9). Thus, boron
supplementation of boron-deprived people
apparently can cause changes in some vari-
ables similar to those induced by estrogen
therapy. (The purpose of estrogen therapy
is to prevent calcium loss and bone loss
which can lead to osteoporosis, bone frac-
tures, and crushed vertebrae.) Some further
evidence from this experiment that boron,
like estrogen, is a substance that can affect
calcium or bone metabolism includes the
finding that, as in the second experiment,
boron supplementation after boron depri-
vation increased serum 25-hydroxychole-
calciferol concentrations (Table 4).
Urinary hydroxyproline is used as an
indicator of changes in bone metabolism.
As shown in Table 4, the urinary excretion
of hydroxyproline significantly increased
during the boron repletion period. This
change suggests that boron increased colla-
gen turnover. Because increased urinary
hydroxyproline usually is associated with
bone loss, this finding is difficult to
explain in light ofthe fact that most ofthe
other changes related to calcium metabo-
lism induced by boron supplementation
after boron deprivation suggest boron has
a positive effect on calcium and bone
metabolism. However, urinary hydrox-
yproline is also derived from collagen syn-
thesis during the breakdown ofthe procol-
lagen N-terminal extension peptides and
of neosynthesized collagen molecules
(10,11). Therefore, it may be possible that
boron supplementation increases active
bone formation and causes a greater need
for collagen (on which calcification is ini-
tiated). As a result, urinary hydroxyproline
is slightly increased. The urinary excretion
of calcium (Table 4) certainly does not
suggest bone breakdown; dietary boron
did not significantly affect this variable.
Because boron apparently influences
calcium and bone metabolism, and
because some of the effects of boron sup-
plementation after a period of boron
deprivation are similar to estrogen thera-
py, boron may be acting in a manner simi-
lar to estrogen in affecting calcium and
bone metabolism. Unfortunately, the
mechanism through which estrogen affects
calcium metabolism has not been clearly
established (12,13), but estrogen appar-
ently can modify the actions of hormones
that affect calcium metabolism. Some of
this modification probably occurs at the
cell membrane level. The possibility that
boron has a similar effect is supported by
findings with plants. They indicate boron
has a regulatory role involving hormones
such as auxin, gibberellic acid, and
cytokinin, and the control of a second
messenger such as calcium at the cell
membrane level (14,15).
Some recent work with rats in my labo-
ratory also supports the possibility that
boron can alter membrane function. In
this experiment, weanling rats were fed
marginally deficient, adequate, and luxuri-
ant amounts ofpotassium (0.18%, 0.36%
and 0.72% of the diet) and two amounts
of boron-0 and 3 mg/kg of diet. After
12 weeks on these diets, blood platelets
were obtained. And, through the use of
the fluorescent marker FURA-2, cellular
ionized calcium concentrations were mea-
sured in the resting stage and after activa-
tion with 0.25 units per ml thrombin with
and without the presence of 1.0 mM
external calcium. Preliminary results sug-
gest that the amount of calcium released
from stores after activation with thrombin
may be decreased by dietary boron.
However, when the platelets were activat-
ed by thrombin in the presence of 1.0 mM
external calcium, the response suggested
that boron caused changes in the cell
membrane that altered calcium transport
in and out of the cell. Increasing potassi-
um increased the transport ofcalcium into
platelets from boron-deprived rats (454 to
548 to 586 nM). In boron-supplemented
rats, the dietary potassium changes did not
have much ofan effect (501 to 501 to 536
nM). These cellular ionized calcium con-
centration findings need to be confirmed
and extended before any conclusive state-
ment can be made about their meaning.
Nonetheless, the hypothesis that boron
and calcium interact to influence hormone
action, transmembrane signaling and/or
membrane function or stability is made
more attractive by these preliminary find-
ings. Moreover, ifthis hypothesis is true, it
provides a simple explanation for the large
variety of effects of varying characteristics
when boron and calcium are altered in the
diet, including those found in the human
experiments described above.
Summary and Conclusions
In summary, boron most likely is an essen-
tial element in the human diet. However,
the exact biochemical function of boron
has not been elucidated. Many findings to
date suggest that boron and calcium action
are interrelated, or that these two elements
affect similar systems that influence many
variables, including the modification of
hormone action, the alteration of cell
membrane characteristics, and/or trans-
membrane signaling. Because of its appar-
ent nutritional importance in calcium
metabolism and utilization, humans
should consume foods luxuriant in boron
(fruits, vegetables, legumes, and nuts).
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